Enfusion, Inc. (ENFN)

Market Cap	1.39B
Revenue (ttm)	201.61M +15.5%
Net Income	2.82M -53.1%
EPS	0.03 -57.7%
Shares Out	129.00M
PE Ratio	356.07
Forward PE	37.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,461,878
Open	10.76
Previous Close	n/a
Day's Range	10.74 - 10.87
52-Week Range	7.83 - 11.80
Beta	0.93
Analysts	Buy
Price Target	12.25 (+13.85%)
Earnings Date	May 8, 2025

About ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and ...

• Industry: Software - Application
• Sector: Technology
• IPO Date: Oct 21, 2021
• Employees: 1,143
• Stock Exchange: NYSE
• Ticker Symbol: ENFN
• Website: https://www.enfusion.com

Financial Performance

In 2024, Enfusion's revenue was $201.61 million, an increase of 15.51% compared to the previous year's $174.54 million. Earnings were $2.82 million, a decrease of -55.41%.

Analyst Summary

According to 3 analysts, the average rating for ENFN stock is "Buy." The 12-month stock price target is $12.25, which is an increase of 13.85% from the latest price.

Price Target

$12.25

(13.85% upside)

Analyst Consensus: Buy